Skip to content

Auron Ther­a­peu­tics

Under­standing tissue differ­en­ti­a­tion to find new cancer therapies

First Investment: 2022

In some kinds of cancer cells, the genetic pathways that guide the normal process of development and differ­en­ti­a­tion are disrupted, leading to uncon­trolled tumor growth. Auron gathers large multi-omic datasets documenting gene and protein expression in normal cells, and applies machine learning to identify the pathways that have been co-opted in tumor cells. Then it can target these hijacked pathways with new therapies to block tumor cell growth. The company can also identify cancer patients who are more likely to respond to specific therapies.

Explore Companies